Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for non-surgical lumbar disc herniation
ACTRN12613001074785Phase 2Not yet recruiting
- Sponsor
- Daniel F Fouladi
- Start
- Sep 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ciprofloxacin and amoxicillin + clavulanate in Herniated Lumbar Disk (3 arms), sponsored by Daniel F Fouladi. Primary endpoint: Pain score according to visual analogue scale (VAS). Planned start Sep 2013; status: not yet recruiting.
02
Drugs
ciprofloxacinamoxicillin + clavulanate
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on ACTRN12613001074785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001074785.